ARQT - Arcutis inks licensing deal to launch psoriasis cream in Asia
2023-08-10 09:14:59 ET
More on Arcutis Biotherapeutics
- Arcutis Biotherapeutics, Inc. ( ARQT ) Q2 2023 Earnings Call Transcript
- Arcutis Biotherapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Arcutis: Zoryve - A Challenging Launch With Progress
- Arcutis Biotherapeutics: High OpEx And Crowded Markets Cloud Prospects
- Arcutis down 20% on Q1 bottom and top line misses
For further details see:
Arcutis inks licensing deal to launch psoriasis cream in Asia